Two new studies of a GLP-1 drugs that help manage diabetes found that some patients lost 25% of their body weight.

People with Type 2 diabetes lost an average of nearly 50 pounds on highest dose of Eli Lilly's GLP-1 medication retatrutide, ...

Tirzepatide, sold as Mounjaro and Zepbound, is our most potent weight-loss drug, but it can be made even more effective when ...

Investment advisors are using ETFs to target some of the most exciting parts of the market.

Edward Gillen, 59, woke up one May morning last year and noticed a speck in his eye. The Massachusetts dad of four and beloved softball coach was just about the retire. Meanwhile, his sight was ...

Nearly 1 in 6 children taking GLP-1 drugs developed a nutritional deficiency within a year, raising new concerns about ...

High monthly costs lead to over 80% of weight loss patients to stop taking GLP-1 medications. University of Georgia research found patients hit a sharp drop-off when monthly bills exceed $75.

Doctors and pharmacists have criticised Eli Lilly's new online platform LillyDirect that will dispense certain medicines, ...

Researchers evaluated the association between GLP-1 receptor agonists and cardiovascular outcomes in adults with serious mental illness.

Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide), today announced detailed results from the Phase 3 ...

Foundayo may support significant weight loss throughout menopause, according to a recent analysis set to be presented at the ...

The second of a Series of papers presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) ...